De-Risking Investments in Medical Technology Innovation

Strengthening Decision-Making and Valuation Accuracy in Medical Startups

AvLuigi Negri

Inbunden, Engelska, 2026

Del i serien Springer Series in Healthcare Management and Innovation

1 225 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Fler format och utgåvor

E-bok

1 565 kr

Beskrivning

This book provides medical technology entrepreneurs and their investors with a decision-making methodology based on the scientific approach that maximizes their chances of success. It enriches the understanding of valuation for medical startups, proposing an approach that moves the focus from the sophistication of the forecasting and financial methodologies to the quantitative importance of high-quality business assumptions and the economic impact of each critical business decision. It also provides a complete set of visual, organized, and compelling mental maps tailored to the business of medical technology innovation; maps that visualize and link the medical venture’s decision-making and prediction problems. Their use minimizes the probability of overlooking critical decision problems on the path to successful execution while connecting them through a sequential and hierarchical framework. Finally, the book provides practical, real-life examples of how the scientific approach to decision-making can be used in medical technology startups outside the clinical trial area. The reader is left with various sets of valuable and practical tools that can be individually applied.

Produktinformation

Utgivningsdatum:2026-04-17
Mått:155 x 235 x 24 mm
Vikt:668 g
Format:Inbunden
Språk:Engelska
Serie:Springer Series in Healthcare Management and Innovation
Antal sidor:2
Förlag:Springer Nature Switzerland AG
ISBN:9783032150066

Utforska kategorier

Miljöekonomi inom Ekonomi och Ledarskap
Finansiering inom Ekonomi och Ledarskap
Entreprenörskap inom Ekonomi och Ledarskap

Mer om författaren

Dr Luigi Negri is Founder and CEO for ThinKeen® Global Consulting (Miami, FL, USA) and Venture Partner of Obloo® Ventures Consulting (Milano, Italy). In this role, he has supported investors in the appraisal and valuation of target medical startups, he has been a board member of highly innovative medical startups and served as a member of advisory boards of broader public initiatives focused on evaluating larger populations of life science startups. In the previous twenty years, Luigi has succeeded as an executive in several international corporate assignments with general management responsibilities in the biotechnology and medical devices industry across multiple global corporations and geographical regions. These positions included VP of Northern & Central Europe for Becton Dickinson® (CR Bard), VP of Emerging Markets of Latin America at Baxter Health Care, and Area General Manager for Poland & Russian Federation at Baxter Health Care®.

Innehållsförteckning

Chapter 1:Introduction.- Chapter 2:The Vocabulary of Medical Ventures.- Chapter 3:Why Medical Innovation is so Difficult.- Chapter 4:Minimizing Decision-Making Biases.- Chapter 5:Decision-Making Using a Scientific Approach.- Chapter 6:Mapping Decision-Related Problems in Medical Innovations.- Chapter 7:Deep-Dive into the Mapping of Decision-Related Problems.- Chapter 8:Prioritizing Decision-Related Problems.